Germany: Paul-Ehrlich-Institut [clinicaltrials_resource:60889552004d2ef4eeb936c626cca79d]
Cetuximab in Neoadjuvant Treatment of Non-Resectable Colorectal Liver Metastases (CELIM) [clinicaltrials:NCT00153998]An Evaluation of Immunogenicity and Safety of Two Doses of MVA-nef vs. MVA-BN in HIV-1 Infected Patients [clinicaltrials:NCT00189930]clinicaltrials:NCT00195442A Long Term Roll-over Study to Investigate the Efficacy and Safety of Adalimumab Given Long-term to Patients With Rheumatoid Arthritis [clinicaltrials:NCT00233571]Safety, Immunological Effect and Efficacy of the Combined Application of MPL and Grass Pollen Allergen [clinicaltrials:NCT00241410]clinicaltrials:NCT00254982Safety Study Comparing a Vaccine Transcutaneous Administration to the Intramuscular Route [clinicaltrials:NCT00261001]Safety and Efficacy of House Dust Mite Allergen Extract in the Treatment of Allergic Rhinoconjunctivitis [clinicaltrials:NCT00263549]Safety and Efficacy of Grass Pollen Allergoid in the Treatment of Allergic Rhinoconjunctivitis [clinicaltrials:NCT00263601]clinicaltrials:NCT00263627Safety and Efficacy of House Dust Mite Allergoid in the Treatment of Bronchial Asthma [clinicaltrials:NCT00263640]Efficacy and Safety of a Purified Standardised Bee Venom Preparation [clinicaltrials:NCT00263952]Safety and Efficacy of a Sublingual Specific Immunotherapy With an Extract of a Six Grass Pollen Mixture [clinicaltrials:NCT00264459]Safety and Feasibility Study of Autologous Bone Marrow Cell Transplantation in Patients With Peripheral Arterial Occlusive Disease (PAOD) [clinicaltrials:NCT00282646]Safety and Feasibility Study of Autologous Progenitor Cell Transplantation in Diabetic Neuropathy [clinicaltrials:NCT00282685]Progenitor Cell Therapy in Dilative Cardiomyopathy [clinicaltrials:NCT00284713]Safety and Efficacy of Recombinant Birch Pollen Allergen in the Treatment of Allergic Rhinoconjunctivitis [clinicaltrials:NCT00309062]clinicaltrials:NCT00310466Efficacy and Safety Trial of ALK-depot SQ Mites in Subjects With Atopic Dermatitis [clinicaltrials:NCT00310492]clinicaltrials:NCT00368121Safety and Immunogenicity Study of Recombinant Modified Vaccinia Virus Ankara (MVA) Virus to Treat HIV Infection [clinicaltrials:NCT00386633]GMZ2-Aluminum Hydroxide Phase I, Tübingen [clinicaltrials:NCT00397449]clinicaltrials:NCT00434616Immunogenicity and Reactogenicity of Fluarix™ (Influsplit SSW®) 2007/2008 in People 18 Years Old or Above [clinicaltrials:NCT00476307]PCR-Based Detection of Bacterial Agents in Platelet Concentrates and Whole Blood [clinicaltrials:NCT00482339]clinicaltrials:NCT00504400Efficacy and Safety of Subcutaneous Versus Intravenous ACZ885 in Adult Patients With Established Rheumatoid Arthritis [clinicaltrials:NCT00505089]Docetaxel, Cisplatin (TP) + Radiation +/- Cetuximab in Larynx Carcinoma (CA) [clinicaltrials:NCT00508664]clinicaltrials:NCT00510965clinicaltrials:NCT00520494clinicaltrials:NCT00540631Efficacy and Safety of CDP870 and Methotrexate Compared to Methotrexate Alone in Subjects With Rheumatoid Arthritis [clinicaltrials:NCT00544154]Efficacy and Safety From a Recombinant Folding Variant of Bet v 1 [clinicaltrials:NCT00554983]Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES) [clinicaltrials:NCT00562406]Gene Therapy for Chronic Granulomatous Disease [clinicaltrials:NCT00564759]Haemate HS in Patients With Severe Bleeding Undergoing Valve Replacement Due to Aortic Stenosis [clinicaltrials:NCT00618293]clinicaltrials:NCT00620815Efficacy and Safety From a High-dosed Sublingual Grass Pollen Preparation [clinicaltrials:NCT00623701]A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen [clinicaltrials:NCT00623831]clinicaltrials:NCT00624832
oversight [clinicaltrials_vocabulary:oversight]
Germany: Paul-Ehrlich-Institut [clinicaltrials_resource:60889552004d2ef4eeb936c626cca79d]
Bio2RDF identifier
60889552004d2ef4eeb936c626cca79d
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:60889552004d2ef4eeb936c626cca79d
has dmc [clinicaltrials_vocabulary:has-dmc]
identifier
clinicaltrials_resource:60889552004d2ef4eeb936c626cca79d
title
Germany: Paul-Ehrlich-Institut
@en
type
label
Germany: Paul-Ehrlich-Institut [clinicaltrials_resource:60889552004d2ef4eeb936c626cca79d]
@en